文献速递肿瘤 PET/CT

68Ga-PSMA-11 PET/CT参数综合评估用于鉴别原发性透明细胞肾细胞癌病理特征

Comprehensive evaluation of 68Ga-PSMA-11 PET/CT parameters for discriminating pathological characteristics in primary clear-cell renal cell carcinoma.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2020-07-04

该研究回顾性分析36例原发性透明细胞肾细胞癌(ccRCC)患者术前68Ga-PSMA-11 PET/CT及手术标本,评估肿瘤最大径、平均CT值和SUVmax鉴别WHO/ISUP分级及不良病理(坏死或肉瘤样或横纹肌样特征)的效能。结果示肿瘤直径和SUVmax在WHO/ISUP分级、pT分期及不良病理间差异有统计学意义(均P<0.05),CT值无差异。结论认为68Ga-PSMA-11 PET/CT可有效识别ccRCC侵袭性病理特征。

要点

  • 肿瘤直径鉴别pT分期的截断值6.70,灵敏度86%、特异度88%,AUC 0.91(95%CI 0.79-1.00,P<0.001)。
  • SUVmax鉴别WHO/ISUP 3-4级与1-2级的截断值16.4,灵敏度100%、特异度71%,AUC 0.89(95%CI 0.81-0.98,P<0.001)。
  • SUVmax鉴别不良病理阳性与阴性的截断值18.5,灵敏度94%、特异度87%,AUC 0.92(95%CI 0.85-0.99,P<0.001)。

核心结论

  • 68Ga-PSMA-11 PET/CT可有效识别ccRCC的侵袭性病理特征。

研究设计与样本

  • 回顾性分析36例原发性ccRCC患者,均有术前68Ga-PSMA-11 PET/CT扫描及手术标本。
  • 从PET/CT图像获取肿瘤最大径、平均CT值和最大标准摄取值(SUVmax)等放射学参数,并在病理特征亚组间比较。
  • 采用受试者工作特征(ROC)曲线分析评估放射学参数鉴别病理特征的效能,计算曲线下面积(AUC)及95%置信区间(CI)。

主要发现

  • 36例肿瘤WHO/ISUP分级分布:1级9例(25.0%)、2级12例(33.3%)、3级9例(25.0%)、4级6例(16.7%)。
  • 不良病理阳性15例(41.7%)。
  • 肿瘤直径和SUVmax在WHO/ISUP分级、pT分期及不良病理间差异均有统计学意义(均P<0.05),CT值无差异。

关键数值与推荐

  • 肿瘤直径鉴别pT分期的截断值6.70,灵敏度86%、特异度88%,AUC 0.91(95%CI 0.79-1.00,P<0.001)。
  • SUVmax鉴别WHO/ISUP 3-4级与1-2级的截断值16.4,灵敏度100%、特异度71%,AUC 0.89(95%CI 0.81-0.98,P<0.001)。
  • SUVmax鉴别不良病理阳性与阴性的截断值18.5,灵敏度94%、特异度87%,AUC 0.92(95%CI 0.85-0.99,P<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate parameters derived from 68Ga-PSMA-11 PET/CT images for discriminating pathological characteristics in primary clear-cell renal cell carcinoma (ccRCC). METHODS: The study retrospectively examined data for 36 ccRCC patients with preoperative 68Ga-PSMA-11 PET/CT scan and surgical specimens. Radiological parameters including maximal tumor diameter, mean CT value, and maximal standard uptake value (SUVmax) were derived from PET/CT images. Pathological characteristics included WHO/ISUP grade and adverse pathology (tumor necrosis or sarcomatoid or rhabdoid feature). Values of radiological parameters were compared within subgroups of pathological characteristics. Receiver operating characteristic (ROC) curve analysis was used for the effectiveness of radiological parameters in differentiating pathological characteristics, estimating area under the ROC curve (AUC) and 95% confidence intervals (CIs). RESULTS: The WHO/ISUP grade distribution for 36 tumors was grade 1, 9 (25.0%); grade 2, 12 (33.3%); grade 3, 9 (25.0%); and grade 4, 6 (16.7%). Adverse pathology was positive for 15 (41.7%). Radiological tumor diameter and SUVmax significantly differed by WHO/ISUP grade, pT stage, and adverse pathology (all P < 0.05), with no difference by CT value. Tumor diameter demonstrated sensitivity 86% and specificity 88% for pT stage, with cutoff 6.70 and AUC 0.91 (95% CI, 0.79-1.00, P < 0.001). SUVmax could effectively differentiate WHO/ISUP grade (3-4 vs. 1-2) and adverse pathology (positive vs. negative), with AUC 0.89 (95% CI, 0.81-0.98, P < 0.001), cutoff 16.4, sensitivity 100%, and specificity 71% and AUC 0.92 (95% CI, 0.85-0.99, P < 0.001), cutoff 18.5, sensitivity 94%, and specificity 87%, respectively. CONCLUSION: 68Ga-PSMA-11 PET/CT could effectively identify aggressive pathological features of ccRCC.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Gao J, Xu Q, Fu Y, et al. Comprehensive evaluation of 68Ga-PSMA-11 PET/CT parameters for discriminating pathological characteristics in primary clear-cell renal cell carcinoma. Eur J Nucl Med Mol Imaging. 2020. PMID: 32623502. doi:10.1007/s00259-020-04916-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。